Patents by Inventor Johannes Hofer

Johannes Hofer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complement split product C4d for the treatment of inflammatory conditions
    Patent number: 10358468
    Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: July 23, 2019
    Assignee: Medizinische Universität Wien
    Inventors: Johannes Hofer, Peter Steinberger, Gerhard Zlabinger, Georg Böhmig, Florian Forster, Judith Leitner, Markus Wahrmann, Margarethe Merio, Johannes Kovarik, Markus Hölzl, David E. Isenman
  • Complement split product C4d for the treatment of inflammatory conditions
    Publication number: 20180265557
    Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.
    Type: Application
    Filed: March 8, 2018
    Publication date: September 20, 2018
    Applicant: Medizinische Universität Wien
    Inventors: Johannes Hofer, Peter Steinberger, Gerhard Zlabinger, Georg Böhmig, Florian Forster, Judith Leitner, Markus Wahrmann, Margarethe Merio, Johannes Kovarik, Markus Hölzl, David E. Isenman
  • Complement split product C4d for the treatment of inflammatory conditions
    Patent number: 9944685
    Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.
    Type: Grant
    Filed: July 2, 2013
    Date of Patent: April 17, 2018
    Assignee: Medizinische Universität Wien
    Inventors: Johannes Hofer, Peter Steinberger, Gerhard Zlabinger, Georg Böhmig, Florian Forster, Judith Leitner, Markus Wahrmann, Margarethe Merio, Johannes Kovarik, Markus Hölzl, David E. Isenman
  • Complement split product C4d for the treatment of inflammatory conditions
    Publication number: 20150191520
    Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methodsAlso antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.
    Type: Application
    Filed: July 2, 2013
    Publication date: July 9, 2015
    Inventors: Johannes Hofer, Peter Steinberger, Gerhard Zlabinger, Georg Böhmig, Florian Forster, Judith Leitner, Markus Wahrmann, Margarethe Merio, Johannes Kovarik, Markus Hölzl, David E. Isenman